---
title: "Archit Organosys Ltd (524640) — Share Price, Financials & Analysis"
symbol: "524640"
company: "Archit Organosys Ltd"
canonical: "https://tapetide.com/stocks/524640"
isin: "INE078I01011"
nse_symbol: "ARCHITORGANOSYSLTD"
bse_code: "524640"
sector: "Chemicals"
industry: "Commodity Chemicals"
market_cap_cr: 137.23
generated_at: "2026-09-13T19:16:36.954Z"
---

# Archit Organosys Ltd (524640)

Canonical page: https://tapetide.com/stocks/524640

## Company

- **NSE Symbol:** ARCHITORGANOSYSLTD
- **BSE Code:** 524640
- **ISIN:** INE078I01011
- **Sector:** Chemicals
- **Industry:** Commodity Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** architorg.com

## About

Incorporated in 1989, Archit Organosys Ltd 
does manufacturing and trading of chemicals 
and organics[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:54:01.966734Z.

- **Market Cap:** ₹137.23 Cr
- **Classification:** Microcap
- **P/E (reported):** 18
- **EPS (TTM):** ₹3.62
- **EPS (reported):** ₹0.36
- **Book Value:** ₹37.15
- **Price to Book:** 1.76
- **Dividend Yield:** 1.53%
- **ROE:** 5.11%
- **ROCE:** 9.33%
- **Debt to Equity:** 0.32
- **Revenue (yearly):** ₹115.6 Cr
- **Net Income:** ₹3.3 Cr
- **EBITDA:** ₹9.2 Cr
- **52-Week High:** ₹67
- **52-Week Low:** ₹34
- **RSI (14):** 61.83

## Tapetide Score

- **Score:** 61 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Rising
- **Percentile:** 90.4 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 47.96 | 9% |
| growth | 48.63 | 9% |
| momentum | 98.09 | 12% |
| ownership | 50 | 24% |
| quality | 75.22 | 22% |
| valuation | 50.5 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- The company has delivered a poor sales growth of 8.32% over past five years.
- Company has a low return on equity of 6.71% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -41.42% | -86.93% | 131.88% |
| ebitda margin growth | 143.75% | -50.31% | — | — |
| net income growth | 460% | -70.8% | -6% | 9% |
| revenue growth | 38.74% | -10.8% | 3% | 8% |
| roce | — | -58.31% | — | — |
| roe | -489.13% | -72.18% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 26.39 | 24.81 | 30.99 | 27 | 29.54 | 25.87 | 43.18 | 33.2 | 32.86 | 38.4 | 36.5 | 37.08 |
| Expenses | 24.28 | 23.71 | 30.7 | 23.95 | 26.69 | 23.21 | 38.76 | 29.06 | 30.16 | 33.72 | 31.61 | 33.71 |
| Operating Profit | 2.11 | 1.1 | 0.29 | 3.05 | 2.85 | 2.66 | 4.42 | 4.14 | 2.7 | 4.68 | 4.89 | 3.37 |
| OPM % | 8 | 4.43 | 0.94 | 11.3 | 9.65 | 10.28 | 10.24 | 12.47 | 8.22 | 12.19 | 13.4 | 9.09 |
| Other Income | 0.54 | 0.52 | 4.11 | 0.47 | 0.63 | 0.93 | 1.06 | 1 | 1.46 | 0.9 | -0.47 | 0.6 |
| Interest | 0.65 | 0.77 | 0.64 | 0.62 | 0.78 | 0.47 | 0.71 | 0.6 | 0.67 | 0.56 | 0.46 | 0.44 |
| Depreciation | 1.49 | 1.49 | 1.48 | 1.49 | 1.5 | 1.49 | 1.46 | 1.49 | 1.52 | 1.52 | 1.49 | 1.5 |
| Profit before tax | 0.51 | -0.64 | 2.28 | 1.41 | 1.2 | 1.63 | 3.31 | 3.05 | 1.97 | 3.5 | 2.47 | 2.03 |
| Tax % | 27.45 | -29.69 | 21.49 | 29.08 | 15 | 37.42 | 38.67 | 33.11 | 21.83 | 30.86 | 18.22 | 28.57 |
| Net Profit | 0.37 | -0.46 | 1.79 | 1.01 | 1.02 | 1.01 | 2.02 | 2.04 | 1.54 | 2.43 | 2.02 | 1.45 |
| EPS in Rs | 0.18 | -0.22 | 0.87 | 0.49 | 0.5 | 0.49 | 0.98 | 0.99 | 0.75 | 1.18 | 0.98 | 0.71 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 82 | 84 | 77 | 95 | 138 | 128 | 113 | 126 | 141 | 145 |
| Expenses | 78 | 87 | 73 | 83 | 121 | 108 | 106 | 113 | 125 | 129 |
| Operating Profit | 4 | -3 | 4 | 11 | 17 | 20 | 7 | 13 | 16 | 16 |
| OPM % | 4.6 | -3.6 | 4.6 | 12 | 12 | 15 | 6 | 10 | 12 | 11 |
| Other Income | 3 | 3 | 2 | 0 | 1 | 3 | 6 | 3 | 3 | 2 |
| Interest | 4 | 4 | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before tax | 0 | -6 | -1 | 5 | 11 | 15 | 4 | 8 | 11 | 10 |
| Tax % | -32 | -25 | 1 | -7 | 28 | 26 | 24 | 33 | 27 | — |
| Net Profit | 1 | -5 | -1 | 5 | 8 | 11 | 3 | 5 | 8 | 7 |
| EPS in Rs | 0.34 | -3.14 | -0.53 | 3.34 | 4.01 | 5.57 | 1.63 | 2.46 | 3.91 | 3.62 |
| Dividend Payout % | 0 | 0 | 0 | 15 | 19 | 9 | 0 | 0 | 26 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10 | 15 | 15 | 15 | 15 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 17 | 25 | 20 | 19 | 26 | 31 | 41 | 44 | 49 | 56 |
| Borrowings | 31 | 36 | 37 | 33 | 30 | 34 | 31 | 26 | 28 | 25 |
| Other Liabilities | 12 | 26 | 12 | 16 | 17 | 18 | 27 | 18 | 26 | 25 |
| Total Liabilities | 70 | 101 | 84 | 83 | 87 | 104 | 120 | 108 | 123 | 127 |
| Fixed Assets | 47 | 47 | 47 | 50 | 48 | 45 | 50 | 60 | 54 | 50 |
| CWIP | 1 | 8 | 5 | 1 | 3 | 13 | 14 | 1 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 6 | 7 |
| Other Assets | 22 | 46 | 32 | 32 | 37 | 44 | 52 | 42 | 62 | 70 |
| Total Assets | 70 | 101 | 84 | 83 | 87 | 104 | 120 | 108 | 123 | 127 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2 | -4 | 3 | 8 | 11 | 11 | 18 | 10 | 19 | 3 |
| Cash from Investing Activity | -35 | -9 | 1 | -1 | -3 | -12 | -12 | -2 | -21 | 4 |
| Cash from Financing Activity | 32 | 13 | 0 | -9 | -7 | 2 | -7 | -9 | -1 | -6 |
| Net Cash Flow | 0 | 0 | 4 | -2 | 1 | 2 | 0 | -1 | -4 | 1 |
| Free Cash Flow | -32 | -13 | 3 | 6 | 8 | 0 | 9 | 15 | 18 | 1 |
| CFO/OP | 75 | -90 | -97 | 221 | 99 | 71 | 108 | 164 | 150 | 30 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 86 | 140 | 62 | 94 | 97 | 72 | 107 | 72 | 67 | 64 |
| Inventory Days | 27 | 41 | 30 | 22 | 21 | 22 | 16 | 16 | 18 | 11 |
| Days Payable | 80 | 126 | 55 | 88 | 87 | 51 | 110 | 62 | 94 | 65 |
| Cash Conversion Cycle | 33 | 56 | 38 | 28 | 30 | 44 | 13 | 26 | -8 | 10 |
| Working Capital Days | 19 | 12 | -23 | -39 | -15 | 0 | 10 | 10 | 45 | 40 |
| ROCE % | 9 | 6 | -4 | 3 | 12 | 18 | 17 | 4 | 11 | 13 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.37% | 62.37% | 63.26% | 64.65% | 64.65% | 64.84% | 65.3% | 65.39% | 65.39% | 65.86% | 65.88% | 65.88% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 32.77% | 33.3% | 32.66% | 31.32% | 31.44% | 31.2% | 30.78% | 30.62% | 30.21% | 29.97% | 29.99% | 29.82% |
| Others | 4.86% | 4.33% | 4.07% | 4.04% | 3.91% | 3.96% | 3.92% | 3.99% | 4.39% | 4.17% | 4.13% | 4.3% |
| No. of Shareholders | 11597 | 11409 | 11298 | 10596 | 10389 | 10198 | 9972 | 9947 | 9847 | 9630 | 9446 | 8959 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 4 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 64.91 | Buy |
| EMA (10) | 65.19 | Buy |
| SMA (20) | 64.29 | Buy |
| EMA (20) | 64.09 | Buy |
| SMA (50) | 60.49 | Buy |
| EMA (50) | 61.12 | Buy |
| SMA (100) | 56.89 | Buy |
| EMA (100) | 57.04 | Buy |
| SMA (200) | 48.91 | Buy |
| EMA (200) | 52.17 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 65.77 | Neutral |
| MACD (12,26,9) | 1.5 | Buy |
| Stochastic (14,3,3) | 87.31 | Sell |
| ADX (14) | 24.63 | Neutral |
| Williams %R (14) | -2.53 | Sell |
| ATR (14) | 2.65 | High Volatility |
| ROC (12) | 5.44 | Buy |
| Stoch RSI (14) | 91.6 | Sell |
| UO (7,14,28) | 64.25 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21ea3a84-6e06-4e97-affe-ba5ab3340f55.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d135b33c-2e1c-4378-ac36-565d2bc56099.pdf) |
| 2026-09-07 | [Notice Of Annual General Meeting To Be Held On 30-09-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=071506d5-0432-43e7-bde7-2a4153d2a321.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of Board Meeting For Increase In Authorised Share Capital And Issue And Allotment Of Equity Shares Through Preferential Basis](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76db76b1-2eec-48fa-b811-52767d0a707e.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Issue of Securities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75fab818-0563-4dff-b612-8ddf9a14071c.pdf) |
| 2026-09-03 | [Record Date For Purpose Of Final Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31482ddf-9e36-4df0-a9e5-0b571b19205f.pdf) |
| 2026-08-27 | [Board Meeting Intimation for Proposal For Issue Of Securities On Preferential Basis As May Be Decided By Board Of Directors](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0149a63b-1ceb-47c5-b261-1f87b7c53c1e.pdf) |
| 2026-08-27 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0caf443b-422a-4dc6-99d2-a5e1bcf9c328.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74c3c094-6baf-48d0-a89f-90596f293f4f.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Approval Of Unaudited Financial Result For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5d0e2c4-9d31-4e30-9b52-d682c2eba532.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Approval Of Unaudited Financial Result For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45d3a8df-6e27-4c25-b96d-230d21e5ddd2.pdf) |
| 2026-05-16 | [Results - Financial Results For The March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26a31712-3921-456c-89d7-7ecc1c965483.pdf) |
| 2026-02-07 | [Approval Of Unaudited Financial Result For The Quarter And Nine Months Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaa6579d-b664-4af4-ad7b-0ed2a4dd24c0.pdf) |
| 2025-11-13 | [Unaudited Financial Result Of The Company For The Quarter And Half Year Ended On 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34ffeea-69c5-4ee2-82ab-5eb15e9031d5.pdf) |
| 2025-08-13 | [Results- Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=681bc7c6-0965-40e4-8335-eaf52385193b.pdf) |
| 2025-02-14 | [The Standalone Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e2e9dc1-a9d2-4454-993a-aac58d431898.pdf) |
| 2024-11-14 | [Results- Financial Results For Quarter And Half Year Ended 30Th September 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f656184-ba1e-4a6a-b412-540e96434fa4.pdf) |
| 2024-08-08 | [Results - Unaudited Financial Results For Quarter Ended On 30Th June 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b54d1722-94e5-466f-9cda-ad718d09a9e5.pdf) |
| 2024-05-30 | [Audited Standalone And Consolidated Results For Financial Year Ended On 31St March 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df8d1a37-595e-4316-b9a3-ba239567184f.pdf) |
| 2024-02-14 | [Results - Financial Results For December 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a95c503-b902-4374-8fb8-f4675a61ce08.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Newspaper advertisement - published for the financial result pertaining to quarter and nine months ended on 31st December, 2025 in Western Time (English and Gujarati) … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Feb - Newspaper advertisement - published for the financial result pertaining to quarter and nine months ended on 31st December, 2025 in Western Time (English and Gujarati) …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98b2769a-aab1-44e2-ae52-3a32b0664660.pdf) |
| 7h - Archit Organosys says price movement is market-driven, with no undisclosed corporate action. | [Reply To Clarification On Price Movement 7h - Archit Organosys says price movement is market-driven, with no undisclosed corporate action.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b5dfc4c2-1aa9-40be-a013-e72b4662a318.pdf) |
| 7 Feb - Approved unaudited results to Dec 31, 2025: Q3 revenue Rs3,930.05 lakh; Q3 net profit Rs243.48 lakh. | [Board Meeting Outcome for Approval Of Unaudited Financial Result Of The Company For The Quarter And Nine Month Ended December 31 2025 7 Feb - Approved unaudited results to Dec 31, 2025: Q3 revenue Rs3,930.05 lakh; Q3 net profit Rs243.48 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/00d0daae-0cc2-4190-81d9-c0eb1249aed8.pdf) |
| 31 Jan - Board approved Q3/9M FY26 unaudited standalone and consolidated results for period ending 31-12-2025; limited review reports recorded. | [Un-Audited Financial Results Q3-FY 2025-26 31 Jan - Board approved Q3/9M FY26 unaudited standalone and consolidated results for period ending 31-12-2025; limited review reports recorded.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/634775a7-bafd-4b1b-84d2-422f0c7c05c8.pdf) |
| 31 Jan - Approved unaudited standalone/consolidated Q3 and nine-month results for period ended 31-Dec-2025; limited review reports recorded. | [Board Meeting Outcome for Outcome Of Board Meeting Held On January 31, 2026 31 Jan - Approved unaudited standalone/consolidated Q3 and nine-month results for period ended 31-Dec-2025; limited review reports recorded.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4db12cb4-3e83-4618-a094-c71a4cc9d62e.pdf) |
| 3 Feb - Board meeting on Feb 7, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed. | [Board Meeting Intimation for Prior Intimation Of Board Meeting To Consider And Approve The Unaudited Financial Result For The Quarter Ended 31.12.2025 3 Feb - Board meeting on Feb 7, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fcbdf699-dfd7-401e-aeff-53721fc1f747.pdf) |
| 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results declaration for March 31, 2026 year-end. | [Closure of Trading Window 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results declaration for March 31, 2026 year-end.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6ad6a9e-608f-43e1-93c7-4ecc61cc2534.pdf) |
| 24 Jan - Board meeting Jan 31, 2026 to approve unaudited Q3/9M results and material related-party transactions. | [Board Meeting Intimation for Board Meeting For Q3- FY 2025-26 24 Jan - Board meeting Jan 31, 2026 to approve unaudited Q3/9M results and material related-party transactions.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f5bedd71-dc15-4d47-9376-0141f47272c7.pdf) |
| 24 Apr - Archit Organosys says price movement is market-driven, with no undisclosed corporate action. | [Reply To Clarification On Price Movement 24 Apr - Archit Organosys says price movement is market-driven, with no undisclosed corporate action.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5dfc4c2-1aa9-40be-a013-e72b4662a318.pdf) |
| 22 Jan - Certificate under Reg.74(5) for quarter ended 31 Dec 2025 from MUFG Intime (RTA). | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 22 Jan - Certificate under Reg.74(5) for quarter ended 31 Dec 2025 from MUFG Intime (RTA).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a09b1f3-36d8-4a44-92c1-f8b4d5a8d304.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd02b96f-e71d-4155-8882-582354cabee6.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/193a0483-014b-4e7b-aad5-f7dcf5a3a2a1.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1376e7ee-6622-4683-bf18-41ddf9bbce77.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/452495d1-ee6f-4a73-bbe6-0591960f1cc7.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b9b5e370-8260-48f5-a6ec-d7f24e713c98.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f3777f84-b85f-450e-aa0f-5a5e6ae78fa1.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eae60387-e0ba-4c9c-b5cf-d71c76ac0762.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fb2e139c-626e-4612-8c8a-72432cf2febc.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fad9eb53-0a09-45c4-be5d-4cccb283c19a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1faca3c4-67d6-4f0d-bd81-c8a14a115af8.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/89892c2d-3cae-4ccc-ae27-6f39a2b57061.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3900480-eaa7-48eb-8340-d9c2b7251bbb.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f057cb5f-5aef-453c-9520-e435d02c9d3a.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543193/74927543193.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524640/74326524640.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/543193/70764543193.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524640/69698524640.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:36.954Z.